-+ 0.00%
-+ 0.00%
-+ 0.00%

Seres Therapeutics Secures $3.6 Million CARB-X Grant to Develop Liquid SER-155 for Infection Prevention

Reuters·10/29/2025 11:00:59

Please log in to view news